Home › Malattie polmonari interstiziali › South Carolina › Charleston
Studi clinici su Malattie polmonari interstiziali a Charleston, SC
13 studi su Malattie polmonari interstiziali cercano partecipanti presso sedi a Charleston e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
In reclutamentoFase 3
- Lowcountry Lung and Critical Care, Charleston
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
In reclutamentoFase 3
- Medical University of South Carolina, Charleston
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
In reclutamentoFase 2
- MUSC, Charleston
SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
In reclutamento
- Medical University of South Carolina, Charleston
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
In reclutamentoFase 2
- Medical University of South Carolina, Charleston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
In reclutamentoFase 2
- Clinical Research Site, Charleston
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
In reclutamento
- Medical University of South Carolina, Charleston
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
In reclutamentoStudio osservazionale
- Medical University of South Carolina, Charleston
Platform Clinical Study for Conquering Scleroderma
In reclutamentoFase 2
- Medical University of South Carolina (MUSC), Charleston
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
In reclutamentoStudio osservazionale
- Medical University of South Carolina, Charleston
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
In reclutamentoFase 3
- Medical University of South Carolina-Nexus, Charleston
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
In reclutamentoStudio osservazionale
- Medical University of South Carolina, Charleston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
In reclutamentoFase 2
- aTyr Investigative Site, Charleston
Studi su Malattie polmonari interstiziali in altre città
- New York City, NY18 studi
- Philadelphia, PA16 studi
- Los Angeles, CA14 studi
- Kansas City, KS13 studi
- Durham, NC13 studi
- Chicago, IL12 studi
- Houston, TX12 studi
- Aurora, CO11 studi
- Ann Arbor, MI11 studi
- Salt Lake City, UT9 studi
- Dallas, TX9 studi
- Boston, MA9 studi
Altri studi a Charleston
- Depressione19 studi
- Ictus18 studi
- Insufficienza cardiaca18 studi
- Cancro del polmone non a piccole cellule16 studi
- Disturbo da stress post-traumatico16 studi
- Malattie cardiovascolari15 studi
- Cancro alla prostata15 studi
- Cancro (tutti i tipi)14 studi
- Carcinoma a cellule squamose della testa e del collo14 studi
- Morbo di Parkinson13 studi
- Cancro al seno12 studi
- Cancro ai polmoni11 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.